Dostarlimab and niraparib in primary advanced ovarian cancer. Hardy-Bessard AC, Pujade-Lauraine E, Moore RG, Montestruc F, et al. Ann Oncol 2025 May 30:S0923-7534(25)00201-7. doi: 10.1016/j.annonc.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Hardy-Bessard AC, Pujade-Lauraine E, Moore RG, Montestruc F, et al. Dostarlimab and niraparib in primary advanced ovarian cancer. Ann Oncol 2025 May 30:S0923-7534(25)00201-7. doi: 10.1016/j.annonc.2025.
PMID: 40461381